Hims & Hers plummets 13% after first-quarter loss, weak earnings guidance

May 13, 2026 - 10:02

Hims & Hers plummets 13% after first-quarter loss, weak earnings guidance

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.

Related Posts

Morgan Stanley boosts price targets for China indexes, sees upside through 2Q 2027

Morgan Stanley boosts price targets for China indexes, ...

May 13, 2026

CNBC Daily Open: Wall Street meets its old nemesis: Inflation

CNBC Daily Open: Wall Street meets its old nemesis: Inf...

May 13, 2026

The stock market isn't ignoring Iran. It's rising for these three very real reasons

The stock market isn't ignoring Iran. It's rising for t...

May 13, 2026

$2B test for the art market: Here's what to know

$2B test for the art market: Here's what to know

May 13, 2026

Auto-state lawmakers seek to keep certain Chinese vehicles out of U.S. as Trump heads to Beijing

Auto-state lawmakers seek to keep certain Chinese vehic...

May 13, 2026

United Airlines flight attendants ratify new contract with 31% raises this summer

United Airlines flight attendants ratify new contract w...

May 13, 2026